Case Reports
The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide
Affiliations
- PMID: 16485889
Item in Clipboard
Case Reports
The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide
J Drugs Dermatol.
2006 Feb.
Abstract
We report the incidence of varicella zoster virus (VZV) and herpes simplex virus (HSV) infection in patients with multiple myeloma and colon cancer who were treated with arsenic trioxide for their disease. In this report, we discuss the effects of arsenic on immune system, and suggest arsenic compounds as a possible predisposing factor for viral reactivation in these patients.
Similar articles
-
Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge.J Am Acad Dermatol. 2005 Nov;53(5):890-2. doi: 10.1016/j.jaad.2005.07.030. J Am Acad Dermatol. 2005. PMID: 16243151
-
Herpes zoster during treatment with arsenic trioxide.Ann Hematol. 2004 Jun;83(6):408. doi: 10.1007/s00277-004-0863-x. Epub 2004 Mar 18. Ann Hematol. 2004. PMID: 15034759 No abstract available.
-
Herpes zoster during treatment with arsenic trioxide.Ann Hematol. 2004 Mar;83(3):198-200. doi: 10.1007/s00277-003-0749-3. Epub 2003 Oct 8. Ann Hematol. 2004. PMID: 15064871
-
Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.J Clin Oncol. 2005 Apr 1;23(10):2396-410. doi: 10.1200/JCO.2005.10.217. J Clin Oncol. 2005. PMID: 15800332 Review.
-
[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].Dtsch Med Wochenschr. 2007 Feb 16;132(7):330-6. doi: 10.1055/s-2007-959329. Dtsch Med Wochenschr. 2007. PMID: 17286223 Review. German. No abstract available.
Cited by
-
The mechanistic basis of arsenicosis: pathogenesis of skin cancer.Cancer Lett. 2014 Nov 28;354(2):211-9. doi: 10.1016/j.canlet.2014.08.016. Epub 2014 Aug 27. Cancer Lett. 2014. PMID: 25173797 Free PMC article. Review.
-
Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).Environ Health Perspect. 2015 Jun;123(6):590-6. doi: 10.1289/ehp.1408731. Epub 2015 Jan 30. Environ Health Perspect. 2015. PMID: 25636148 Free PMC article.
-
Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.PLoS Pathog. 2011 Feb 3;7(2):e1001266. doi: 10.1371/journal.ppat.1001266. PLoS Pathog. 2011. PMID: 21304940 Free PMC article.
-
Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.Virology. 2011 Jul 20;416(1-2):86-97. doi: 10.1016/j.virol.2011.04.005. Epub 2011 May 24. Virology. 2011. PMID: 21605886 Free PMC article.
-
Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.J Virol. 2013 Apr;87(8):4571-83. doi: 10.1128/JVI.03443-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408604 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical